BSE filing, NSE: CELLO. Summary written from the filing by ALFA Finder's alert engine.
Cello World Ltd: key numbers
- Share price
- ₹370.00
- Market cap
- ₹8,173 Cr
- Revenue (annual)
- ₹2,324 Cr
- Net profit (annual)
- ₹331.5 Cr
- P/E (TTM)
- 26.1×Sector 43.7×
- Promoter holding
- 73.50%-1.50% QoQ
- FII holding
- 2.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cello World Ltd
All →Cello World Q2 FY27 Results: Net Profit ₹81.9 Cr, Down 10.3% YoY
Cello World Ltd reported revenue from operations of ₹633.2 Cr (+7.8% YoY) and net profit of ₹81.9 Cr (-10.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹81.9 Cr · -10.3% YoY
Cello World Board Meeting Date
Cello World will hold a board meeting on 05 Nov 2026 to consider September 2026 quarter results. Trading window remains closed until 14 Nov 2026.
Cello World Other Announcement
Cello World Ltd has filed its shareholding pattern for the quarter ended September 30, 2026. This is a routine quarterly compliance disclosure under SEBI regulations.
Cello World Price Movement Clarification
Cello World clarified that the recent increase in its security's trading volume is purely market-driven, confirming no undisclosed price-sensitive information exists.
Cello World Other Announcement
Cello World Limited filed a report certifying the completion of fractional entitlement compensation to eligible shareholders, as required by the Composite Scheme of Amalgamation.
Cello World Other Announcement
Cello World Ltd has filed its quarterly shareholding pattern disclosure as required by SEBI regulations. This is a periodic compliance filing with no actionable corporate event.
Other other announcement announcements
All →Austere Systems Other Announcement
Austere Systems appointed EquiBridgeX Advisors as its Investor Relations and Public Relations agency effective November 5, 2026. The filing states no fees or financial terms.
Kiri Industries Other Announcement
Kiri Industries filed the Crisil monitoring agency report for the quarter ended September 30, 2026. The report covers utilisation of preferential warrant issue proceeds with no deviations.
Sahajanand Medical Technologies Other Announcement
Sahajanand Medical Technologies appointed Amit Jaste & Associates as Secretarial Auditor for 60 months, effective 5 November 2026. Approved at the same-day board meeting.
- Execution
- 60 months
Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Span Divergent Other Announcement
Span Divergent approved leasing Ahmedabad property to material subsidiary Dryfruit Factory LLP. Rent is capped at ₹3 lakh monthly under an arm's-length related-party transaction.
Finkurve Financial Services Other Announcement
Finkurve Financial Services filed its Regulation 52(7) statement on use of Rs. 26 crore from its NCD issue, quarter ended September 2026. The statement reports no deviation or variation in use of proceeds.